Our strong relationship with GI physicians and key opinion leaders began with the introduction of the company’s innovative diagnostic tools that have helped physicians manage the IBD patient journey. We are leveraging these relationships, our GI Biobank & advanced data mining techniques to develop breakthrough diagnostic tools that help patients and physicians from diagnosis, through disease progression, therapy selection and monitoring.
UC: Ulcerative Colitis CD: Crohn’s Disease
|PL-200CD/UC||Dosing Optimization||IBD Population|
|PL-300UC||Disease Monitoring||Assay Feasibility|
|PL-400CD||Therapy Selection||IBD Population|